WASHINGTON, DC — Patients taking amantadine are at risk for corneal edema, according to investigators whose case study earned a "Top 5 Poster" award here at Optometry's Meeting by the American ...

Findings of post hoc analyses published in JAMA Ophthalmology suggest that preoperative Scheimpflug imaging can help predict corneal edema resolution following Descemet membrane endothelial ...

As reported by Henick and colleagues in 1994, removal of retained anterior chamber nuclear fragments after cataract surgery can lead to visual and symptomatic improvement. As surgical techniques and ...

Please provide your email address to receive an email when new articles are posted on . A 79-year-old woman was referred to the Cornea Service for progressive corneal edema and decreased vision in the ...

The Food and Drug Administration recently approved a new contact lens for the treatment of corneal edema —an eye condition that causes swelling, fluid build up, blurred vision, haziness and scarring.

Dublin, Feb. 11, 2025 (GLOBE NEWSWIRE) -- The "Corneal Edema - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering. A comprehensive report has been released ...

MENLO PARK, Calif., Oct. 8, 2024 /PRNewswire/ -- Emmetrope Ophthalmics, LLC ("Emmecell"), a clinical-stage biotechnology company pioneering the discovery and development of cell-based therapies for ...

SAN DIEGO--(BUSINESS WIRE)--Trefoil Therapeutics, a clinical-stage biotechnology company focused on developing novel new therapeutic agents to treat corneal diseases, today announced a series of data ...

MENLO PARK, Calif., Sept. 22, 2020 /PRNewswire/ -- Emmetrope Ophthalmics LLC ("Emmecell"), a clinical-stage biotechnology company pioneering the discovery and development of cell-based therapies for ...

A 36 year - old man was referred to our institute with complaints about pain in both eyes, blurred vision especially on awakening and bilateral progressive visual loss, worse in the left eye. His ...

In the US, the market mainly consisted of Corticosteroids and Non-steroidal anti-inflammatory drugs (NSAIDs), and others, which generated nearly USD 489 million in 2022. Emerging therapies for corneal ...